Outcome metrics in recommended performance measurement tools for emergency department performance evaluation: a systematic review
Abstract
Background: There is no established protocol for measuring the overall performance of an emergency department (ED). This study sought to evaluate in terms of outcome measures the existing measurement tools created for ED use.
Design: A comprehensive systematic literature review was conducted following the PRISMA guidelines. A systematic literature search was performed in databases of Medline and Scopus using the following eligibility criteria: (1) article context is the hospital ED; (2) the purpose is to develop or use a measurement tool concerning either quality or value; (3) the measurement tool evaluates the overall ED performance; (4) the measurement tool consists of more than two single performance indicators; and (5) the article is published in English.
Main results: Fifteen unique articles met the eligibility criteria and were included in the systematic review. The Delphi method was the most popular method for identifying the recommended performance indicators for ED use. Ten articles defined outcome metrics as a separate category of indicators. The indicators perceived as outcome metrics differed widely among the studies. The outcome metrics recommended can be divided into the following five dimensions: reattendances, mortality, diagnostic and procedural errors and complications, diagnosis-specific survival rates, and patient experience. Forty-six single outcome metrics were identified. Reattendances were the most frequently recommended outcome metrics, with 20…
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.